Literature DB >> 22081575

Controlled gene expression in bifidobacteria by use of a bile-responsive element.

Lorena Ruiz1, Pablo Álvarez-Martín, Baltasar Mayo, Clara G de los Reyes-Gavilán, Miguel Gueimonde, Abelardo Margolles.   

Abstract

The promoter activity of the upstream region of the bile-inducible gene betA from Bifidobacterium longum subsp. longum NCC2705 was characterized. DNA fragments were cloned into the reporter vector pMDYAbfB, and the arabinofuranosidase activity was determined under different in vitro conditions. A segment of 469 bp was found to be the smallest operational unit that retains bile inducibility. The reporter activity was strongly affected by the presence of ox gall, cholate, and conjugated cholate, but not by other bile salts and cell-surface-acting compounds. Remarkably, this bile-inducible system was also active in other bifidobacteria containing betA homologs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081575      PMCID: PMC3255758          DOI: 10.1128/AEM.06611-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  25 in total

1.  Improvement of the representation of bifidobacteria in fecal microbiota metagenomic libraries by application of the cpn60 universal primer cocktail.

Authors:  Janet E Hill; W M Ursla Fernando; Gordon A Zello; Robert T Tyler; Wendy J Dahl; Andrew G Van Kessel
Journal:  Appl Environ Microbiol       Date:  2010-04-30       Impact factor: 4.792

2.  Microbiomic analysis of the bifidobacterial population in the human distal gut.

Authors:  Francesca Turroni; Julian R Marchesi; Elena Foroni; Miguel Gueimonde; Fergus Shanahan; Abelardo Margolles; Douwe van Sinderen; Marco Ventura
Journal:  ISME J       Date:  2009-03-19       Impact factor: 10.302

3.  Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

Authors:  Michelle Cronin; David Morrissey; Simon Rajendran; Shereen M El Mashad; Douwe van Sinderen; Gerald C O'Sullivan; Mark Tangney
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

Review 4.  Treatment and prevention of antibiotic associated diarrhea.

Authors:  E Bergogne-Bérézin
Journal:  Int J Antimicrob Agents       Date:  2000-12       Impact factor: 5.283

5.  Active efflux of bile salts by Escherichia coli.

Authors:  D G Thanassi; L W Cheng; H Nikaido
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

6.  An interactive regulatory network controls stress response in Bifidobacterium breve UCC2003.

Authors:  Aldert Zomer; Matilde Fernandez; Breda Kearney; Gerald F Fitzgerald; Marco Ventura; Douwe van Sinderen
Journal:  J Bacteriol       Date:  2009-09-04       Impact factor: 3.490

7.  Purification and functional characterization of a novel alpha-L-arabinofuranosidase from Bifidobacterium longum B667.

Authors:  Abelardo Margolles; Clara G de los Reyes-Gavilán
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

Review 8.  Bifidobacteria: from ecology to genomics.

Authors:  Francesca Turroni; Douwe van Sinderen; Marco Ventura
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in Bifidobacterium breve UCC2003.

Authors:  Mary O'Connell Motherway; Jonathan O'Driscoll; Gerald F Fitzgerald; Douwe Van Sinderen
Journal:  Microb Biotechnol       Date:  2008-12-03       Impact factor: 5.813

10.  Improvement of bacterial transformation efficiency using plasmid artificial modification.

Authors:  Kazumasa Yasui; Yasunobu Kano; Kaori Tanaka; Kunitomo Watanabe; Mariko Shimizu-Kadota; Hirofumi Yoshikawa; Tohru Suzuki
Journal:  Nucleic Acids Res       Date:  2008-11-12       Impact factor: 16.971

View more
  8 in total

Review 1.  Gut and root microbiota commonalities.

Authors:  Shamayim T Ramírez-Puebla; Luis E Servín-Garcidueñas; Berenice Jiménez-Marín; Luis M Bolaños; Mónica Rosenblueth; Julio Martínez; Marco Antonio Rogel; Ernesto Ormeño-Orrillo; Esperanza Martínez-Romero
Journal:  Appl Environ Microbiol       Date:  2012-10-26       Impact factor: 4.792

Review 2.  A Resource for Cloning and Expression Vectors Designed for Bifidobacteria: Overview of Available Tools and Biotechnological Applications.

Authors:  Lorena Ruiz; Maria Esteban-Torres; Douwe van Sinderen
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Exploring Bacterial Attributes That Underpin Symbiont Life in the Monogastric Gut.

Authors:  Gerald W Tannock
Journal:  Appl Environ Microbiol       Date:  2022-08-29       Impact factor: 5.005

4.  Using fluorescent promoter-reporters to study sugar utilization control in Bifidobacterium longum NCC 2705.

Authors:  S Duboux; J A Muller; F De Franceschi; A Mercenier; M Kleerebezem
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

5.  Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions.

Authors:  Verena Grimm; Marita Gleinser; Caroline Neu; Daria Zhurina; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

Review 6.  Accessing the inaccessible: molecular tools for bifidobacteria.

Authors:  Zhongke Sun; Annika Baur; Daria Zhurina; Jing Yuan; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2012-05-11       Impact factor: 4.792

Review 7.  Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.

Authors:  Olivia Cano-Garrido; Joaquin Seras-Franzoso; Elena Garcia-Fruitós
Journal:  Microb Cell Fact       Date:  2015-09-16       Impact factor: 5.328

Review 8.  Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.

Authors:  Rodrigo D De Oliveira Carvalho; Fillipe L R do Carmo; Alberto de Oliveira Junior; Philippe Langella; Jean-Marc Chatel; Luis G Bermúdez-Humarán; Vasco Azevedo; Marcela S de Azevedo
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.